Wells Fargo’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $243M | Buy |
|
|||||
|
2025
Q1 | $177M | Sell |
|
|||||
|
2024
Q4 | $198M | Buy |
|
|||||
|
2024
Q3 | $198M | Buy |
|
|||||
|
2024
Q2 | $165M | Sell |
|
|||||
|
2024
Q1 | $176M | Buy |
|
|||||
|
2023
Q4 | $42.4M | Sell |
|
|||||
|
2023
Q3 | $39.3M | Sell |
|
|||||
|
2023
Q2 | $56M | Sell |
|
|||||
|
2023
Q1 | $55.8M | Sell |
|
|||||
|
2022
Q4 | $77.8M | Sell |
|
|||||
|
2022
Q3 | $77.2M | Buy |
|
|||||
|
2022
Q2 | $56.5M | Sell |
|
|||||
|
2022
Q1 | $81.9M | Buy |
|
|||||
|
2021
Q4 | $91.2M | Sell |
|
|||||
|
2021
Q3 | $119M | Sell |
|
|||||
|
2021
Q2 | $130M | Sell |
|
|||||
|
2021
Q1 | $135M | Sell |
|
|||||
|
2020
Q4 | $422M | Buy |
|
|||||
|
2020
Q3 | $129M | Sell |
|
|||||
|
2020
Q2 | $142M | Buy |
|
|||||
|
2020
Q1 | $74.6M | Sell |
|
|||||
|
2019
Q4 | $218M | Buy |
|
|||||
|
2019
Q3 | $76.9M | Buy |
|
|||||
|
2019
Q2 | $88.1M | Sell |
|
|||||
|
2019
Q1 | $102M | Sell |
|
|||||
|
2018
Q4 | $169M | Buy |
|
|||||
|
2018
Q3 | $165M | Buy |
|
|||||
|
2018
Q2 | $135M | Sell |
|
|||||
|
2018
Q1 | $126M | Sell |
|
|||||
|
2017
Q4 | $128M | Buy |
|
|||||
|
2017
Q3 | $125M | Buy |
|
|||||
|
2017
Q2 | $109M | Sell |
|
|||||
|
2017
Q1 | $102M | Sell |
|
|||||
|
2016
Q4 | $87.9M | Buy |
|
|||||
|
2016
Q3 | $86.8M | Buy |
|
|||||
|
2016
Q2 | $52.4M | Sell |
|
|||||
|
2016
Q1 | $50.7M | Buy |
|
|||||
|
2015
Q4 | $59.2M | Sell |
|
|||||
|
2015
Q3 | $52.7M | Sell |
|
|||||
|
2015
Q2 | $88.2M | Buy |
|
|||||
|
2015
Q1 | $78M | Sell |
|
|||||
|
2014
Q4 | $64.6M | Buy |
|
|||||
|
2014
Q3 | $51.5M | Sell |
|
|||||
|
2014
Q2 | $57.9M | Sell |
|
|||||
|
2014
Q1 | $59.4M | Buy |
|
|||||
|
2013
Q4 | $54M | Sell |
|
|||||
|
2013
Q3 | $55.4M | Buy |
|
|||||
|
2013
Q2 | $42.9M | Buy |
|